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vinyl chloride/heavy metalsAbstract Traditional risk factors do not explain all of the risk for incident coronary heart disease
(CHD) events. Human susceptibility to atherosclerosis and consequently coronary heart disease is
maximally exhibited when the environment is unfavorable, especially in workplace. Thus, the pres-
ent work was undertaken to study the relation of lipoprotein (a) to the other atherogenic risk fac-
tors in young workers occupationally exposed to vinyl chloride or some heavy metals by studying
the effect of exposure to these agents on the lipid proﬁles, immunological parameters and the anti-
oxidant defense enzyme system. The results of this study revealed that, in metalists, the cluster
features of dyslipidemia, impairment in antioxidant defense mechanism and high levels of Lp (a),
CICs, C3 and C4 represent unfortunate events on their cardiovascular system. In VCW, vinyl
chloride metabolites caused severe oxidative stress reﬂected by impairment in the antioxidant
defense accompanied by propagation of lipid peroxidation. Additionally, the elevated levels of
Predictive values of some atherogenic risk factors 101Lp (a), CICs, C3 and C4 may point out to their role as atherogenic risk factors in those workers. In
conclusion, young workers occupationally exposed to VC may be at high risk of developing cardio-
vascular disease in spite of having normolipidemia.
ª 2014 King Saud University. Production and hosting by Elsevier B.V. This is an open access article under
the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).Contents
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The clinical presentations of atherosclerosis mainly involve the
coronary and carotid arteries, which remain as the leading
causes of morbidity and mortality in both men and women
of all racial groups with coronary heart disease (CHD) the
leading cause of death worldwide (Cutler et al., 2006). The
presence of CHD is considered to be a reliable index for more
widespread of atherosclerosis. The disease develops slowly
over many years in the intimae layer of large and medium sized
arteries, with devastating manifestations usually after the
fourth or ﬁfth decade (Grifﬁn, 1999).
Atherosclerosis is a complex disease involving genetic and
environmental risk factors, acting on their own or in synergy
(Chen et al., 2007). Classical risk factors such as hypertension,
diabetes, and obesity are useful as predicators of atherosclerotic
disease (Lamon and Hajjar, 2008). However, environmental
factors are considered key determinants of cardiovascular dis-
ease (CVD). Although lifestyle choices such as smoking, diet,
and exercise are viewed as major environmental inﬂuences,
the contribution of pollutants and environmental chemicals is
less clear. Moreover, occupation has been linked to CVD inci-
dence and mortality, but few studies have investigated occupa-
tion in relation to early atherosclerotic disease (Fujishiro et al.,
2011). However, accumulating evidence suggests that exposure
to pollutants and chemicals could elevate the risk of cardiovas-
cular disease. Exposures to arsenic, lead, cadmium, pollutant
gases, solvents, and pesticides have also been linked to increased
incidence of CVD (Bhatnagar, 2006).
On the other hand, lipoprotein (a) (Lp a) is a low density
lipoprotein-like particle synthesized by the liver that consists
of an apolipoprotein B100 molecule covalently linked to a very
large glycoprotein known as apolipoprotein (a) (Anuurad
et al., 2006). The physiological and vascular effects of the par-
ticle remain uncertain, but Lp(a) has been shown to enter the
arterial intimae of humans (Nielsen et al., 1997); in vitro and
animal studies have reported that Lp (a) can promote throm-
bosis, inﬂammation, and foam cell formation. (Boffa et al.,
2004). Recently, it has been concluded that under a wide range
of circumstances, there are continuous, independent, and mod-
est associations of Lp a concentration with the risk of CHD
and stroke that appear exclusive to vascular outcomes (Erqou
et al., 2009). Moreover, many prospective epidemiologicalstudies have reported positive associations of baseline Lp (a)
concentration with CHD risk (Bennet et al., 2008). Further-
more, it has been reported that the risk attributed to Lp a
may be reduced by aggressively tackling other vascular risk
factors, such as low-density lipoprotein cholesterol (Tziomalos
et al., 2009).
However, identiﬁcation of individuals at risk before the
development of atherosclerosis-related diseases is important
for preventive cardiology. Accordingly, the present work was
undertaken to study the relation of Lp (a) to the other athero-
genic risk factors in young workers occupationally exposed to
vinyl chloride or some heavy metals. This was achieved by
studying the effect of exposure to those agents on the lipid pro-
ﬁles, immunological parameters and the antioxidant defense
enzyme system.
2. Methods
In order to achieve these goals, 90 subjects were included in
this study and divided into four groups; group (I): 15 healthy
subjects with no history of ischemic heart disease with mean
age of 33.3 ± 7.4 years, group (II): 15 patients of ischemic
heart disease (IHD) with mean age of 46.1 ± 3.6 years who
were diagnosed in the Department of Internal Medicine-Cardi-
ology Unit-Medical Research Institute-Alexandria University,
group (III): 20 vinyl chloride workers (VCW) with matched
age of 37.5 ± 4.5 years and group (IV): 40 metalist workers
(MW) with mean age of 35.7 ± 7.8 years. According to the
Research Ethics Board of Medical Research Institute-Alexan-
dria University, a signed formal consent was obtained from all
the participants in the present study. Healthy subjects, IHD
patients and workers were investigated by complete clinical
examination (general and systemic).
Blood samples were collected from healthy subjects, IHD
patients, VC and heavy metal workers after overnight fast.
These samples were divided into two aliquots; ﬁrst one was
used for the determination of serum concentrations of iron,
copper and aluminum using a PerkinElmer atomic absorption
spectrophotometer-2380 (Brown et al., 1984). Also, serum was
utilized for the determination of lipid peroxides (Satoh, 1978),
total cholesterol (TC), determined according to Allain et al.,
1974 where, free cholesterol was released from its esters after
enzymatic hydrolysis and oxidation. The intensity of the color
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Figure 1 Levels of (mean± S.E.) of serum lipoprotein a (mg/dL)
in different studied groups. p1: Comparison with healthy control
(C). p2: Comparison with ischemic heart disease IHD patients.
p3: Comparison between vinyl chloride workers (VCW) and
metal workers (MW). p: Values were considered signiﬁcant at
level <0.05.
102 A.A.A. Saad et al.is proportional to the concentration of cholesterol present in
the sample. HDL-cholesterol (HDL-C) (Roeschlau et al.,
1974) depending on the usage of Mg2+and dextran sulfate pre-
cipitates all fractions of serum lipoproteins except the HDL.
After centrifugation the HDL fraction remains in the superna-
tant. LDL-cholesterol (LDL-C) (Friedewald et al., 1972) and
triglycerides (TGs) (Bachorik et al., 1991) were determined
after enzymatic hydrolysis by lipase. The indicator is a
quinoneimine formed when hydrogen peroxide reacts in the
presence of peroxidase with 4-chlorophenol and 4-aminoanti-
pyrine. Lipoprotein a (Lp a) (Walton et al., 1974) by determi-
nation of the concentrations present is performed by the
turbidimetric measurement of the maximum reaction velocity
(peak rate method). Serum immunologic parameters including
circulating immune complexes (CICs), complements 3 and 4
(C3 & C4) were also measured (Johnson, 1993) where, circulat-
ing immune complexes were determined by precipitation with
polyethylene glycol. The concentrations present are deter-
mined quantitatively by the turbidimetric measurement of
the maximum reaction velocity. Moreover, serum activity level
of c-glutamyl transferase (GGT) was determined depending on
the rate of formation of p-nitroaniline (Szasz, 1969). In the sec-
ond aliquot, erythrocytes were separated and their lyzates were
utilized for the determination of glutathione concentration
level (GSH) as well as the activity levels of glutathione perox-
idase (GPx) and glutathione reductase (GR) (Beutler et al.,
1963; Paglia and Valentine, 1967; Beutler, 1969).
3. Results
In patients with ischemic heart disease (IHD), the levels of
total cholesterol (TC), low density lipoprotein-cholesterol
(LDL-C), low density lipoprotein-cholesterol (HDL-C) and
triglycerides (TGs) were signiﬁcantly elevated when compared
to those in healthy subjects (p= 0.0001). Also, the level of
lipoprotein (a) signiﬁcantly raised (p= 0.001) (Fig. 1). Serum
levels of iron and cupper insigniﬁcantly changed when com-
pared to that in healthy subjects, p> 0.05 (Fig. 2). Interest-
ingly, serum level of aluminum was signiﬁcantly higher than
that in healthy subjects, p= 0.002, as shown in Fig. 2. Immu-
nologic parameters including circulating immunecomplexes
(CICs), complement-3 (C3) and complement-4 (C4) signiﬁ-
cantly elevated, p= 0.0001, p= 0.0001 and p= 0.005, respec-
tively (Fig. 3). Oxidative markers showed a signiﬁcant increase
in the MDA level, p= 0.0001 (Fig. 4), accompanied by a sig-
niﬁcant reduction in the GSH content (p= 0.0001) and the
activities of glutathione peroxidase (GPx) and glutathione
reductase (GRd), p= 0.015 and p= 0.001, respectively
(Fig. 5). Meanwhile, the serum activity level of c-glutamyl
transferase (GGT) was insigniﬁcantly different from that in
healthy subjects (p> 0.05), Fig. 5.
In vinyl chloride workers’ (VCW) group, the levels of TC,
LDL-C, HDL-C and TGs were insigniﬁcantly different from
those in healthy subjects (p> 0.05). However, the level of lipo-
protein (a) signiﬁcantly increased in those workers when com-
pared to that in healthy subjects, p= 0.037 (Fig. 1). Serum
levels of iron, copper and aluminum insigniﬁcantly changed
when compared to that in healthy subjects, p> 0.05 (Fig. 2).
Immunologic markers, CICs, C3 and C4 were signiﬁcantly
higher in those workers than that in healthy subjects,
p= 0.007, p= 0.005 and p= 0.024, respectively, as shownin Fig. 3. A signiﬁcant increase in serum MDA level,
p= 0.019, was observed in those workers when compared to
that in healthy subjects (Fig. 4). This was associated with a sig-
niﬁcant decrease in the GSH content (p= 0.0001) and the
activities of GPx and GRd, p= 0.0001, as shown in Fig. 5.
Meanwhile, the serum activity level of GGT was signiﬁcantly
higher than that in healthy subjects (p= 0.004) (Fig. 5).
In metal workers’ (MW) group, the levels of TC, LDL-C,
HDL-C and TGs signiﬁcantly elevated when compared to those
in healthy subjects (p= 0.002, p= 0.002, p= 0.002 and
p= 0.004, respectively). Moreover, the level of lipoprotein (a)
signiﬁcantly increased (p= 0.001) (Fig. 1). Furthermore, serum
levels of iron, copper and aluminum signiﬁcantly increased
when compared to that in healthy subjects (p= 0.044,
p= 0.0001 and p= 0.0001, respectively) (Fig. 2). On the other
hand, immunologic markers, CICs, C3 and C4 were signiﬁ-
cantly higher than those in healthy subjects, p= 0.0001,
p= 0.013 and p= 0.004, respectively, as shown in Fig. 3.
For oxidative markers, a signiﬁcant increase in serum MDA
level, p= 0.0001, was observed in those workers when com-
pared to that in healthy subjects (Fig. 4). This was associated
with a signiﬁcant decrease in the GSH content (p= 0.0001),
the activities of GPx and GRd, p= 0.0001 and p= 0.001,
respectively, and the signiﬁcant elevation in serum activity level
of GGT (p= 0.04) when compared with that in healthy sub-
jects (Fig. 5).
4. Discussion
The present study was undertaken to investigate the relation of
Lp (a) to the other atherogenic risk factors in young workers
occupationally exposed to vinyl chloride or some heavy metals.
In the MW group as well as IHD patients, the levels of TC,
LDL-C and TGs signiﬁcantly elevated whereas the HLD-C le-
vel signiﬁcantly reduced. Disturbed lipid proﬁle is one of the
most important and potent risk factors in IHD (Maharjan
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Figure 2 Levels of (mean ± S.E.) (a) serum iron (lg/dL), (b) serum Copper (lg/dL) and (c) serum aluminum (lg/L) in the different
studied groups. p1: Comparison with healthy control (C). p2: Comparison with ischemic heart disease IHD patients. p3: Comparison
between vinyl chloride workers (VCW) and metal workers (MW). p: values were considered signiﬁcant at level <0.05.
Predictive values of some atherogenic risk factors 103et al., 2008). The proportionate distribution of cholesterol in
HDL and LDL fractions is necessarily important for health
equilibrium and that disturbed lipid proﬁle with low HDL-
cholesterol and high LDL-cholesterol is an established cogent
risk factor in initiation, progression and also in precipitation of
IHD (Kasper et al., 2005). Also, elevated triglycerides and tri-
glycerides rich-lipoproteins may have a role in contributing to
the progression of mild-moderate atherosclerotic lesions,
whereas elevations in cholesterol-rich lipoproteins (e.g.,
LDL-C) facilitate progression of severe lesions. Patients with
elevations in both triglyceride and LDL-C fractions appear
to be at increased cardiovascular risk compared to those with
isolated elevations in either parameter, and individuals with
the lipid triad may derive more pronounced cardio-protectivebeneﬁts from certain treatments than patients with elevated
LDL-C alone (Abdel-Maksoud et al., 2008). Accordingly,
the data may indicate that the magnitude of rise of TC,
LDL-C and TGs was severe enough to implicate them as ma-
jor determinants of IHD risk in the metalists group. This is in
addition to the signiﬁcant reduction in HDL-C level in those
workers.
Also, the data of the present study indicated a signiﬁcant in-
crease in the Lp (a) level in metalists and VCW groups as well
as in IDH patients. Previous cohort studies have demonstrated
an association between elevated Lp (a) levels and increased
risk of IHD (Rifai et al., 2004; Danik et al., 2006). Further-
more, a stepwise increase in the risk of myocardial infarction
and IHD with increasing levels of Lp (a) has been reported
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Figure 3 Levels of (mean ± S.E.) (a) serum circulating immune complexes (O.D), (b) serum complement-3 (mg/dL) and (c) serum
complement-4 (mg/dL) in different studied groups. p1: Comparison with healthy control (C). p2: Comparison with ischemic heart disease
IHD patients. p3: Comparison between vinyl chloride workers (VCW) and metal workers (MW). p: values were considered signiﬁcant at
level <0.05.
104 A.A.A. Saad et al.(Kamstrup et al., 2008). Thus, Lp (a) could inﬂuence risk of
myocardial infarction and IHD either through promotion of
atherosclerosis or increased risk of thrombosis. Previous stud-
ies have implicated Lp (a) in the process of atherogenesis
including entry into the arterial intima and promotion of foam
cell formation, smooth muscle cell proliferation, and plaque
inﬂammation and instability (Nielsen et al., 1997; Boffa
et al., 2004; Deb and Caplice, 2004). This may indicate that
the metalists and VCW groups are at high risk of developing
atherosclerosis and consequently CVD.
In metalists, a signiﬁcant elevation in serum Fe, Cu and Al
concentrations has been observed. This increase could be
attributed to occupational exposure to these metals. Anyhow,
there is compelling mechanistic evidence for the potential roleof iron in atherosclerosis: the role of iron in oxidizing low-den-
sity lipoprotein (LDL), iron chelators prevent endothelial cell
damage by oxidized LDL, the ability of iron to cause endothe-
lial cell damage, and iron chelators prevent endothelial cell
dysfunction and vascular smooth muscle proliferation (Shah
and Alam, 2003). Also, circulating copper oxidizes LDL cho-
lesterol (Arai et al. 2005; Ahuja et al. 2006). Low density lipo-
protein (LDL) oxidation is a crucial step in atherosclerosis
(Brites et al. 2006). The elevated levels of these metals, espe-
cially iron and copper, may reﬂect that metalists have addi-
tional risk factor for atherogenesis beside their disturbed
lipid proﬁle.
The data of the present work revealed a signiﬁcant eleva-
tion in the aluminum level in IHD patients. It should be noted
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different studied groups. p1: Comparison with healthy control (C).
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Predictive values of some atherogenic risk factors 105that no direct evidence has been linked to aluminum as a risk
factor for IDH. Also, the level of aluminum in IHD patients
has not previously reported. However, aluminum can act as
a pro-oxidant by stabilizing reduced iron the initiating species
for lipid peroxidation, and by inhibiting the antioxidant action
of ﬂavonoid (Yoshino et al., 1999). Furthermore, it has been
indicated that the pro-oxidant effect of aluminum may be indi-
rect and concentration independent (Ogasawara et al., 2003).
Therefore, additional investigations should be taken to clarify
the role of aluminum as pro-oxidant in atherogenesis.
A signiﬁcant elevation in the levels of CICs, C3 and C4 has
been observed in MW, VCW and IDH patients. Previously,
the increased levels of CICs in IHD patients have been re-
ported (Kardaszewicz et al., 1991). Atherosclerosis is now rec-
ognized as a chronic inﬂammatory disease and is characterized
by features of inﬂammation at all stages of its development. It
also appears to display elements of autoimmunities and several
auto-antibodies including those directed against oxidized low-
density lipoprotein and heat shock proteins have been identi-
ﬁed in atherosclerosis. Circulating Immune complexes (CICs)
may form between these antigens and autoantibodies and via
Fc receptor signaling and complement activation may modu-
late the inﬂammation in atherosclerosis (Burut et al., 2010).
The most likely reason for enhanced CICs formation accompa-
nying atherosclerosis in humans seems to be cholesterol (Lec-
omte et al., 1995), especially LDL-C (Kiener et al., 1995).
Also, complement possesses numerous functions related to
host defense, plays a role in clearing immune complexes
including formation of interfaces between innate and adaptive
immunity by recruiting and activating inﬂammatory cells (The´-
roux and Martel, 2006). Although the complement system is
part of the host defense response, considerable evidence
suggests that complement plays an important role in thepathophysiology of IHD (Iltumur et al., 2005). All of these
may indicate the involvement of CICs and both of C3 and
C4 the atherogenesis in mentalist and VC workers.
The data of the present study showed a reduction in the
GSH level in IHD patients. It is widely recognized that vascu-
lar endothelial responses to inﬂammation and oxidative reac-
tions play critical roles in atherogenesis (Libby, 2002). The
generally accepted paradigm is that oxidative damage to low-
density lipoprotein produces a particle with proatherogenic
properties, including the ability to initiate an inﬂammatory re-
sponse (Berliner et al., 2001). Inﬂammation in turn produces
reactive oxygen and/or nitrogen species to modulate cell func-
tion that can further promote oxidative damage to biomole-
cules, propagating tissue injury. In this context, adhesion
molecules mediate monocyte adhesion to the endothelium,
whereas cellular GSH limits/prevents oxidative damage there-
by protecting the cell and inhibiting inﬂammatory reactions
(Kevil et al., 2004). In mammalian cells, glutathione and the
glutathione peroxidases constitute the principal antioxidant
defense system (Ursini et al., 1995). GPx plays an important
role in the cellular defense against oxidant stress by utilizing
GSH to reduce lipid hydroperoxides and hydrogen peroxide
to their corresponding alcohols. Glutathione reductase that
catalyzes the reduction of oxidized glutathione (GSSG) to
the reduced form of GSH (Meister and Anderson, 1983) is
therefore, an important component of GSH-antioxidant sys-
tem. As previously reported (Motghare et al., 2001), a signiﬁ-
cant decrease in GPx and GRd was observed in IHD patients.
It is known that GPx, as well as GRd, can be inactivated by
oxidant species. For instance, 4-hydroxynonenal, an aldehydic
byproduct of lipid peroxidation generated during LDL oxida-
tion conceivably in the vascular wall (Esterbauer et al., 1992)
has been reported to inactivate GPx (Pigeolet et al., 1990).
Furthermore, the catalytic activity of GGT, which is present
on the surface of cell membranes and in serum, is responsible
for the extracellular catabolism of the antioxidant glutathione.
Cysteinyl glycine deriving from the hydrolysis of glutathione
performed by GGT has been found to trigger iron-dependent
production of reactive oxygen species as well as low-density
lipoprotein oxidation. The localization of GGT within the cor-
onary plaque provides a pathological basis for the hypothesis
of a direct participation of GGT in low-density lipoprotein
oxidation within the plaque and in atherogenesis and coronary
artery disease progression (Paolicchi et al., 2004). Accordingly,
the elevated GGT activity might be a risk factor for atherogen-
esis in IDH patients. Meanwhile, it may be suggested that
GSH-antioxidant system (GSH and its related enzymes) is a
sensitive and reliable index for monitoring oxidative status in
atherosclerosis due to its deep implication in atherosclerosis
progressing.
For the VCW group, the data showed a reduction in GSH
concentration and signiﬁcant decrease in the activity of GPx
and GRd. Meanwhile, a signiﬁcant elevation in GGT activity
level has been observed. It is known that various adverse bio-
logical effects of vinyl chloride appear to be dependent upon
its metabolic conversion into chemically reactive metabolites
mainly in the liver. The mixed function oxidase system is the
major metabolic route in which vinyl chloride is ﬁrst metabo-
lized to chloroethylene oxide. This unstable epoxide is then
transformed into chloroacetaldehyde which is further con-
verted to chloroethanol or monochloroacetic acid. Chloroeth-
ylene oxide, chloroacetaldehyde and monochloroacetic acid
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106 A.A.A. Saad et al.are the main toxic metabolites of vinyl chloride. It has been re-
ported that chloroacetaldehyde-induced hepatocyte cytotoxic-
ity involved reversible thiol protein adduct formation,
mitochondrial toxicity and lipid peroxidation (Christian and
O’Brien, 1993). It should be noted that conjugation with gluta-
thione is the main detoxiﬁcation mechanism for these three
compounds (Jedrychowski et al., 1984). Thus, the involvement
of GSH in the detoxiﬁcation of vinyl chloride may explain its
depletion. Also, the capability of vinyl chloride to initiate lipid
peroxidation may explain the observed signiﬁcant elevation of
serum MDA level in VC workers and the reduction in the
activity of the GPx and GRd. VCW group. All of these mayindicate that VCW are exposed to oxidative stress due to expo-
sure to vinyl chloride.
On the other hand, accumulating evidence indicates that
exposure to chemicals including the work place leads to gener-
ation of free radicals which if unaccompanied by available
antioxidant leads to oxidative stress (Flora et al., 2008). Thus,
metalists are exposed to oxidative stress that is manifested by
increased levels of lipid peroxidation and decreased antioxi-
dant capacity of GSH-antioxidant system; decreased level of
GSH and the activities of GPx and GRd. Moreover, the eleva-
tion in GGT activity which plays a role in generating ROS may
contribute to oxidative stress establishment.
Predictive values of some atherogenic risk factors 1075. Conclusion
Conclusively, the herein results proved that the elevated con-
centration of iron, copper and aluminum in the sera of the
metalist group induced severe oxidative stress associated with
a salient dyslipidaemia and conspicuous impairment of antiox-
idant defense, which was manifested by panic decrease in the
blood glutathione content level as well as the enzymatic activ-
ity level of erythrocytes glutathione peroxidase and glutathione
reductase.
For vinyl chloride metabolites either the epoxide or chloro-
acetaldehyde caused severe oxidative stress and depletion in
blood glutathione content as well as the enzymatic activity of
glutathione peroxidase and glutathione reductase which exerts
impairment in the antioxidant defense. Then it was followed
by propagation of lipid peroxidation. Also, the level of lipo-
protein (a) highly signiﬁcantly increased.
In conclusion, metalists are at high risk of developing ath-
erosclerosis and consequently CVD. This could be indicated
through the disturbed lipid proﬁle, the elevated levels of metals
(Fe, Cu and Al), impaired immunologic parameters and oxida-
tive stress. Also, VC workers are at high risk of developing
CVD in spite of having normolipidemia.
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